The evaluation of mean platelet volume of children with adenoid hypertrophy
Acta Medica Mediterranea, cilt.34, sa.6, ss.1665-1669, 2018 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 34 Sayı: 6
- Basım Tarihi: 2018
- Doi Numarası: 10.19193/0393-6384_2018_6_255
- Dergi Adı: Acta Medica Mediterranea
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.1665-1669
- Anahtar Kelimeler: Adenoids, Child, Mean Platelet Volume
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Objective: We aimed to compare the platelet distribution width (PDW) and platelet parameters (PLT), particularly MPV values of children who were diagnosed with adenoid hypertrophy at the pediatric clinic with those of healthy children to investigate a relationship between adenoid hypertrophy and MPV values. Material and method: This prospective, cross-sectional study was conducted at the department of pediatrics, Health Sciences University, Ministry of Health Okmeydani Training and Research Hospital between January 2012 and December 2014. The PLT and PDW values as well as MPV of children who were diagnosed with adenoid hypertrophy were compared with those of healthy children. Results: In this study, 120 children with adenoid hypertrophy and 120 healthy children were evaluated. The age range of participants was between 3 years and 16 years, and the mean age was 9.13±2.94 years. The mean MPV value in children with adenoid hypertrophy (10.88 ± 1.15 fL) was statistically significantly higher than that in the control group (9.84 ± 1.04 fL). While the mean platelet distribution width value in the adenoid hypertrophy group was statistically significantly higher than that of the control group, there was no statistically significant difference between the mean platelet counts of both groups. Conclusion: MPV, PLT, and PDW values did not differ significantly in children with adenoid hypertrophy compared to healthy children. MPV values were determined significantly higher in children with adenoid hypertrophy when compared with healthy children. Children with adenoid hypertrophy should be followed up in terms of cardiovascular diseases on the long view.